Skip to main content

Table 1 Clinicopathological characteristics of patients for discovery and clinical validation cohorts

From: Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer

Clinical and pathological variables

Discovery cohort (N = 24)

Validation cohort (N = 56)

Age (years)

  < 60

13

29

  ≥ 60

11

27

Gender

 Male

22

54

 Female

2

2

Smoking status

 Smoker

19

48

 Non-smoker

5

8

Clinical stage

 I-II

14

28

 III-IV

10

28

Differentiation

 Well

0

8

 Moderate

16

27

 Poor

8

21

Lymph node metastasis

 Yes

11

21

 No

13

35